Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression-Reference-Cited by-同舟云学术

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Published:2018-02-02 Issue:6 Volume:32 Page:1427-1434
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Fernández de Larrea Carlos,Isola Ignacio,Pereira Arturo,Cibeira Ma Teresa,Magnano Laura,Tovar Natalia,Rodríguez-Lobato Luis-Gerardo,Calvo Xavier,Aróstegui Juan I.,Díaz Tania,Lozano Ester,Rozman María,Yagüe Jordi,Bladé Joan,Rosiñol Laura

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0013-4.pdf

Reference28 articles.

1. Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121–27.

2. Ravindran A, Bartley AC, Holton SJ, Gonsalves WI, Kapoor P, Siddiqui MA, et al. Prevalence, incidence and survival of smoldering multiple myeloma in the United States. Blood Cancer J. 2016;6:e486.

3. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749–57.

4. Bladé J, Dimopoulos M, Rosiñol L, Rajkumar SV, Kyle RA. Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations. J Clin Oncol. 2010;28:690–97.

5. Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin P, Hodnefield J, et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;356:2582–90.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to Identify and Manage High-Risk Smoldering Multiple Myeloma;Current Oncology Reports;2024-08-23

2. The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma;HemaSphere;2024-05

3. SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-03

4. Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper;British Journal of Haematology;2024-02-23

5. Monoclonal Gammopathies;Comprehensive Hematology and Stem Cell Research;2024